MiRNAs |
miR-27a |
Upregulated |
Directly target PPAR-γ |
– |
mouse model/3T3-L1 |
Inhibit PI3K/Akt pathways |
[54] |
miR-351 |
Downregulated |
Directly target FLOT2 |
GDM |
GDM mice |
Inhibit PI3K/Akt pathways |
[56] |
miR-26b |
Upregulated |
Indirectly target PI3K/Akt signaling pathway |
GDM |
GDM mice |
Inhibit PI3K/Akt pathways |
[103] |
miR-125a-5p |
Downregulated |
Directly target STAT3 |
– |
C57BL/6 mice |
Activate PI3K/Akt pathways |
[60] |
miR-21 |
Upregulated |
Directly target PTEN |
DR |
DR models/RVECs |
Activate PI3K/Akt pathways |
[61] |
Downregulated |
Indirectly regulated by PI3K/Akt |
– |
C57BL/6/Islet cell |
PI3K/Akt pathways induce miR-21 |
[62] |
miR-130b |
Downregulated |
Directly target PTEN |
DE |
PC12/hippocampal cells/Male Wistar rats |
Activate PI3K/Akt pathways |
[64] |
miR-195 |
Upregulated |
Directly target Mfn2 |
– |
C57BL/6J mice/palmitate-stimulated Min6 cells |
Inhibit PI3K/Akt pathways |
[65] |
Upregulated |
Directly target PFKFB4 |
– |
HCC cell lines/HCC tumor |
Inhibit PI3K/Akt pathways |
[104] |
miR-7 |
Downregulated |
Directly target HOXB3 |
DR |
ARPE-19 cell line |
Inhibit PI3K/Akt pathways |
[67] |
Downregulated |
Directly target IRS-1 |
DR |
diabetic rat model/ECs and RPs cells |
Inhibit PI3K/Akt pathways |
[68] |
Downregulated |
Directly target IRS-2 |
DR |
mice model of DR/ECs and RPs cells |
Inhibit PI3K/Akt pathways |
[105] |
miR-363-3p |
Downregulated |
Indirectly target FOXO1 |
insulin resistance |
C57BL/6J mice/HepG2 cells |
Activate PI3K/Akt pathways |
[106] |
miR-19a |
Upregulated |
Directly target PTEN |
DR |
DR rat model |
Inhibit PI3K/Akt pathways |
[71] |
miR-122 |
Upregulated |
Indirectly target PI3K/Akt |
– |
INS-1 |
Inhibit PI3K/Akt pathways |
[107] |
miR-20b-5p |
Upregulated |
Directly target THBS1 |
DR |
DR model |
Inhibit PI3K/Akt pathways |
[108] |
miR-30c |
Downregulated |
Directly target ROCK2 |
DN |
Human DN tissue/HK-2 cells |
Inhibit PI3K/Akt pathways |
[74] |
miR-199a-3p |
Downregulated |
Directly target FGF7 |
DR |
DR rat model//ECs and RPs cells |
Inhibit PI3K/Akt pathways |
[75] |
Downregulated |
Directly target VEGF |
DR |
hRMECs and ARPE-19 cell |
Inhibit PI3K/Akt pathways |
[76] |
Downregulated |
Indirectly target PI3K/Akt |
– |
Peripheral blood samples/HUVECs |
Activate PI3K/Akt pathways |
[77] |
miR-720 |
Upregulated |
Directly target Rab35 |
– |
MIN6 cells/ |
Activate PI3K/Akt pathways |
[78] |
miR-139-5p |
Upregulated |
Directly target PICK1 |
– |
Min6 cells/db/db mice |
Inhibit PI3K/Akt pathways |
[79] |
miR-24 |
Downregulated |
Indirectly target PI3K/Akt |
CAD |
diabetic rats/VSMCs |
Inhibit PI3K/Akt pathways |
[80] |
miR-183 |
Upregulated |
Directly target BTG1 |
DR |
DR rat model |
Activate PI3K/Akt pathways |
[81] |
miR-203 |
Downregulated |
Directly target PIK3CA |
DCM |
DCM mouse model |
Inhibit PI3K/Akt pathways |
[82] |
miR-153 |
Downregulated |
Directly target PAQR3 |
DN |
MCs/renal tissue from DN |
Inhibit PI3K/Akt pathways |
[84] |
miR-23b |
Downregulated |
Directly target HMGA2 |
DN |
db/db mice/HK-2 cells |
Inhibit PI3K/Akt pathways |
[85] |
miR-126 |
Downregulated |
Directly target IRS1 |
DR |
DR rat model/ECs and RPs cells |
Inhibit PI3K/Akt pathways |
[86] |
Downregulated |
Indirectly target PI3K/Akt |
– |
Min6 cells |
Activate PI3K/Akt pathways |
[87] |
Downregulated |
Directly target VEGFA, and PK3R2 |
DR |
RF/6A cells |
Inhibit PI3K/Akt pathways |
[88] |
miR-499-5p |
Downregulated |
Directly target PTEN |
insulin resistance |
db/db mice/NCTC1469 cells |
Activate PI3K/Akt pathways |
[90] |
miR-873 |
Upregulated |
Directly target IGFBP2 |
myocardial injury/insulin resistance |
GDM rat model |
Inhibit PI3K/Akt pathways |
[91] |
lncRNAs |
MEG3 |
Downregulated |
Indirectly target PI3K/Akt |
DR |
DR Rat Models/Microvascular endothelial cells from rat retina |
Inhibit PI3K/Akt pathways |
[92] |
Upregulated |
Directly target miR-370-3p |
GDM |
HUVEC cell |
Inhibit PI3K/Akt pathways |
[109] |
PVT1 |
Downregulated |
Indirectly target PI3K/Akt |
DPN |
DPN Rat Models |
Activate PI3K/Akt pathways |
[110] |
|
Upregulated |
Indirectly target PI3K/Akt |
GDM |
HTR-8/SVneo cell/trophoblast cells |
Activate PI3K/Akt pathways |
[95] |
SNHG16 |
Upregulated |
Directly target miR-146a, and miR-7-5p |
DR |
hRMECs |
Activate PI3K/Akt pathways |
[96] |
RPL13p5 |
Upregulated |
Indirectly target PI3K/Akt |
GDM |
peripheral blood |
Activate PI3K/Akt pathways |
[111] |
UCA1 |
Upregulated |
Indirectly target PI3K/Akt |
DN |
DN rat model |
Activate PI3K/Akt pathways |
[112] |
HOTAIR |
Downregulated |
Indirectly target PI3K/Akt |
DCM |
Myocardial biopsy/AC16 cell |
Activate PI3K/Akt pathways |
[99] |
TUG1 |
Downregulated |
Indirectly target PI3K/Akt |
DN |
DM rats/Mouse-derived mesangial cells |
Inhibit PI3K/Akt pathways |
[113] |
LINC00323 |
Upregulated |
Indirectly target PI3K/Akt |
DN |
blood samples of DN patients |
Activate PI3K/Akt pathways |
[101] |
HEIH |
Upregulated |
Directly target miR-939 |
DR |
ARPE-19/DR patients |
Activate PI3K/Akt pathways |
[102] |